Categories: Drug Research

Dr Reddy’s recalls heart-burn drug over ‘contamination’

Hyderabad, March 14,2014: According to the US Food and Drug Administration, the Hyderabad-based company was recalling 58,656 bottles of the drug due to a microbial contamination.

The recall has been classified as ‘Class II’, which, as per FDA norms, is not a serious problem, with only a remote chance of severe adverse consequences from contamination in the product.

A Dr Reddy’s spokesperson said that it was a voluntary recall and that there was no financial implication.

On the Bombay Stock Exchange, the Dr Reddy’s scrip ended Thursday at Rs. 2,734, up 1.63 per cent.

The Pharma Times News Bureau

Recent Posts

Esaote Group Expands Production in India

Noida, November 08, 2024: Esaote Group, a leading Italian innovator in medical imaging - ultrasound,…

3 hours ago

In Q2 FY25, AGI Greenpac Limited posts EBITDA of ₹166 crore up by 20% Y-o-Y and PAT of Rs ₹72 crore up by 28%

Gurugram, November 08, 2024: AGI Greenpac Limited, a focused Packaging Products company, today announced its financial…

3 hours ago

DKMS-BMST – Bridging the Care Gap in Blood Cancer Treatment on National Cancer Awareness Day

New Delhi, November 07, 2024: National Cancer Awareness Day serves as a poignant reminder of…

24 hours ago

The Arya Vaidya Pharmacy (Coimbatore) Ltd. Strengthens Legacy with New Initiatives and Expanded Product Portfolio

Coimbatore, November 07, 2024: The Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic…

1 day ago

New medical nutrition ingredient combines high-protein with “best taste yet”

New Delhi, November 06, 2024: Arla Foods Ingredients has launched a new whey protein hydrolysate…

2 days ago

6 Early Signs of Ovarian Cancer

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

2 days ago